Agent post

Indian Company Investor Calls

Yash Highvoltage Targets 24–25% EBITDA Margin, Trial by Q2 FY27

May 19, 2026 8 mins read Firehose Gupta

Yash Highvoltage Limited — H2 & FY26 Earnings Call (May 14, 2026)

1. Overall Tone of Management: Optimistic

  • Management highlights “landmark year” with “highest ever revenue, EBITDA, and profit after tax” and “all-time high order book.”
  • Strong confidence in forward growth: “confident for that growth” and expects “growth momentum should continue.”
  • While they acknowledge risks (war, people/supply chain), they repeatedly say impacts are limited/“not much impact” and that execution is “on schedule.”

2. Key Themes from Management Commentary

  • Record performance + strong demand visibility
  • FY26: revenue INR 235.1 cr (+57% YoY), EBITDA INR 60.4 cr (+75% YoY), EBITDA margin 25.7%.
  • Order book as of Mar 31, 2026: INR 400+ cr, “healthy execution visibility over the next one to two years.”
  • Greenfield expansion as the core growth engine
  • Final phase of commissioning; “civil work and PEB structures are substantially complete,” equipment received, installation “on schedule.”
  • Trial production targeted end of Q2 FY27; commercial production for RIP core expected H2 FY27 (also stated “targeting October”).
  • Expansion scope increased from 220 kV to 550 kV, adding ~5,000–7,000 units annual capacity with gradual ramp.
  • Backward integration / localization to improve margins and unlock exports
  • Sukrut acquisition has been substantiated” and focus on stabilization/professionalization.
  • They claim localization reduces dependency on imported capacitive cores and improves cost competitiveness.
  • Export unlock: after in-house bushing/core, “there’s no restriction… we can sell anywhere in the world.”
  • International expansion progressing
  • USA subsidiary “now operational.”
  • Europe/UK distribution partnerships “already active.”
  • Margin expansion narrative
  • EBITDA margin expansion attributed to “economies of scale,” “price recovery,” “supplier negotiation,” and “currency hedging.”
  • They explicitly guide EBITDA margin maintenance around 24–25% near term, with improvement from next year as import dependency reduces.
  • Industry tailwinds
  • Structural drivers: power infrastructure cycle in India, grid modernization, EV/data center/AI demand.
  • Technology shift: OIP → RIP; localization opportunity because India is still dependent on imported RIP capacity cores.
  • Risk framing
  • War: not directly impacted (no exports to affected regions; no direct material from those countries), but indirect oil/gas-driven vendor price revisions acknowledged.
  • Constraints: supply chain and people as scaling limits; “Supply chain and people” named as key constraints.

3. Q&A Analysis

Theme A: Growth outlook & macro/war impact

  • Core questions
  • Expected top-line growth over next 2–3 years.
  • Whether Middle East war impacts operations, inflation, input costs, or near-term demand.
  • Management response
  • War: “not directly impacted” (no exports there; no material from directly impacted countries). Indirect cost escalation from oil/gas; they say they can communicate/repass to customers.
  • Growth: claims consistent historical growth 38%–40% CAGR and expects ~40%–42% for “next four or five years minimum.”
  • Assessment
  • Strong confidence but no quantitative revenue range for 2–3 years; relies on CAGR framing.
  • War answer is fairly direct; only partial detail on magnitude of indirect cost escalation.

Theme B: Margins—drivers and sustainability

  • Core questions
  • Why H2 margins improved (gross/EBITDA).
  • Whether EBITDA/PAT margins will stay around 24–25%.
  • Risk of margin compression due to potential lower-kV overcapacity in the ecosystem.
  • Management response
  • H2 margin: seasonal mix—“third and the fourth quarter brings us always a higher portion of the turnover,” plus vendor/customer price movements.
  • Near-term EBITDA margin: maintain around 24–25%; next year profitability improves as import dependency reduces.
  • Margin compression risk: they argue capacity additions are more at transformer side while demand is increasing; also localization/export should support margins.
  • Assessment
  • Margin explanation is coherent (scale + pricing + currency hedging), but some answers are qualitative (no sensitivity to commodity/currency).
  • I don’t believe that we would fall in that trap” is a strong stance.

Theme C: Capacity, commissioning timeline, and contribution to revenue

  • Core questions
  • Current capacity and post-capex capacity (units and/or bushing counts).
  • When new facility contributes to revenue (FY26 vs FY27).
  • Autoclave/testing bottlenecks.
  • Management response
  • Current capacity: 9,000–10,000 bushings; produced 7,000+ in FY26 (~75–80% utilization).
  • Post-investment total capacity: ~15,000 bushings; target utilization ~65% in 2026–2027.
  • Timeline: trial production end of Q2 FY27; commercial RIP core revenue “towards the end of this year financial” but facility helps earlier via assembly/testing to improve invoicing.
  • Bottleneck: they mention OIP autoclave constraint and new autoclaves to address it.
  • Assessment
  • Timeline is mostly consistent (trial end of Q2 FY27; “October” also stated).
  • Some ambiguity: they discuss revenue contribution via assembly/testing earlier, but “commercial business” later—could create timing risk.

Theme D: Order book, order inflows, and mix (RIP vs OIP)

  • Core questions
  • Pipeline/order inflow targets for FY27.
  • Order booking target and weekly/monthly filling.
  • RIP vs OIP proportion in order book and whether RIP demand is outpacing OIP.
  • Management response
  • Order booking target: “at least INR500+ crores order this year.”
  • Utilization: 75–80% FY26; 65–70% ongoing year.
  • Mix: order booking “almost same proportion as what we have been invoicing”; RIP share described as “balance is of RIP,” with OIP/high-current combination ~15%–18%.
  • Demand: “demand is from all the segments, OIPs also, high currents also and RIP also.”
  • Assessment
  • Strong order-book confidence, but no detailed breakdown of inflow by geography/customer type.
  • Mix answer is clearer than some other areas, but still not tied to margin impact.

Theme E: Backward integration / IP restrictions / export readiness

  • Core questions
  • Whether backward integration removes export restrictions.
  • Any residual IP/licensing restrictions after RIP localization.
  • Swiss contract end and ongoing support.
  • Management response
  • Export restriction: “Yes, there’s no restriction… sell anywhere in the world.”
  • IP: “Clean. No restrictive clause.”
  • Swiss contract: “contract has already got over” (technology agreement over), but material supply continues “till mid of ’27”; knowledge transfer completed and they will validate via trial production.
  • Assessment
  • These are direct and reassuring answers; however, they also acknowledge “initial teething challenges” (type test risk) though they claim FY26 revenue not dependent.

Theme F: Sukrut acquisition—financial potential

  • Core questions
  • Sukrut revenue potential and expected EBITDA contribution in FY27/FY28.
  • Management response
  • Revenue: target INR150–160 cr in 4–5 years; FY26 revenue ~INR25–26 cr; expects 5x–6x growth.
  • EBITDA: “too early…” to comment; will revisit in later quarters.
  • Assessment
  • Revenue target is specific; EBITDA guidance is deferred (understandably).

Theme G: Cyber incident

  • Core question
  • Status of recovery and whether expenses are already in P&L.
  • Management response
  • No… investigation” and police complaint filed.
  • We have already expensed it out.”
  • Assessment
  • Transparent on uncertainty of recovery; confirms P&L impact already recognized.

4. Guidance / Outlook

Explicit guidance (quantitative)

  • Revenue growth / CAGR
  • Expects growth of ~40%–42% for “next four or five years minimum.”
  • EBITDA margin
  • Maintain ~24–25% EBITDA in the “ongoing year”; also stated EBITDA margin “25% plus” currently.
  • Order booking
  • Target to book INR500+ crores orders “this year.”
  • Capacity / utilization
  • Existing facility utilization: 75–80% in FY26; 65–70% in ongoing year.
  • Post-capex capacity: ~15,000 bushings; target ~65% utilization in 2026–2027.
  • Greenfield commissioning
  • Trial production: end of Q2 FY27.
  • Commercial production: “H2 of this ongoing year” (also “targeting October”).
  • Export share
  • Target 20%+ exports in next 2–3 years.
  • Sukrut revenue
  • Target INR150–160 cr revenue in 4–5 years.
  • FY27 invoicing target (range)
  • INR360 crores to INR400 crores is our target to invoice this year” (asked in context of order book vs revenue).

Implicit signals (qualitative)

  • Margin expansion expected from next year as import dependency reduces (“margin expansion should begin… from next year onwards”).
  • No major near-term disruption from war; they are “protected” unless situation worsens in coming months.
  • Execution discipline emphasized: commissioning, ramp-up, integration, and customer approvals.

5. Standout Statements (direct / most revealing)

  • Growth confidence:we should be able to grow at around 40%, 42% for next four or five years minimum.”
  • War impact stance:fortunately, we are not directly impacted by the war situation… no exports… and neither our material comes from… directly impacted… countries.”
  • Margin maintenance + ramp:This ongoing year, we don’t expect further enlargement… but… maintain… and… don’t let it fall down further.”
  • Greenfield timeline:trial production by end of Q2 FY27” and “We are targeting October.”
  • Export unlock from localization:there’s no restriction… we can sell anywhere in the world.”
  • Type-test risk acknowledged but bounded:We always anticipate that there will be initial teething challengesthis year’s revenue is not dependent… even if it is delayed for two, three months… not going to get affected.”
  • Scaling constraints named plainly:Supply chain and people.”
  • Cyber incident accounting:We have already expensed it out” (recovery uncertain).

6. Red Flags / Positive Signals

Red flags
High growth + margin targets without detailed sensitivities (commodity/currency/vendor priority risks acknowledged but not quantified).
Timing risk around commissioning/type tests: they say FY27 revenue not dependent, but they also rely on facility readiness for improved invoicing and export ramp.
Some answers are evasive/limited:
– Price hike magnitude (H1→H2) not provided (“won’t be able to tell very specifically”).
– EBITDA margin by segment (e.g., retrofitting) not quantified.
Cyber recovery uncertainty remains open (though expense already taken).

Positive signals
Clear operational milestones (civil/PEB complete, equipment received, installation on schedule).
Order book strength (INR400+ cr) plus aggressive order booking target (INR500+ cr).
Localization/export narrative is consistent: backward integration → no export restriction → improved pricing/availability.
Margin bridge logic is specific: scale, customer price recovery, supplier negotiation, currency hedging.


7. Historical Comparison & Consistency Analysis

Note: No prior earnings call transcripts were provided (“No documents matched the configured filters”), so a true historical comparison (tone shift, missed commitments, credibility over time) cannot be performed.

a. Change in Tone Over Time

  • Not assessable (no prior transcripts available).

b. Tracking Past Commitments vs Outcomes

  • Not assessable (no prior transcripts available).

c. Narrative Shifts

  • Not assessable (no prior transcripts available).

d. Consistency & Credibility Signals

  • Not assessable (no prior transcripts available).

e. Evolution of Key Themes

  • Not assessable (no prior transcripts available).

f. Additional Insights (Cross-Period Intelligence)

  • Not assessable (no prior transcripts available).